Invest in the Future of Healthcare

EntelMed - Series A-1 Offering

EntelMed is at the forefront of transforming healthcare through strategic acquisitions of cutting-edge medical device companies. Utilizing a proven model and focusing on growth potential, we offer accredited investors a unique opportunity to be part of the next wave of medical advancements.

By investing with us, you're not just funding innovation; you're shaping the future of healthcare.

Preferred

Stock Offering

$2

Share Price

$25k

Minimum Investment

Why Invest In EntelMed?

  • EntelMed will seek to combine multiple companies to reach a

    $2.3 billion valuation.

  • We are targeting the high-growth medical device market because it is highly fragmented and ripe for consolidation.

  • Our approach involves acquiring multiple high-growth companies to merge them into a larger national brand.

  • Our strategy is to accomplish the industry consolidation through

    an IPO.

Summary of Terms

  • Price: $2.00 Per Share.

  • Size of Offering: $5,000,000.

  • Conversion: Each Share may be converted, at any time at the holder’s option, into one share of common stock.

  • Liquidation preference: Each Share has a liquidation preference of $2.00 per Share.

  • Investor Suitability: Accredited investors only.

  • Risk Factors: Prospective investors should carefully consider the factors set forth under “Risk Factors” in the PPM.

Management Team

Bruce Lisanti, PhD

CEO

Sapna Ravula, MD

CMO

Joseph Barr

CTO

Advisors

Peter Shaw, PhD

AI and Biotech

Fabio Persia, PhD

Scientist

Daniella D'Auria, PhD

Medical Robotics

Have Questions?

Book A Call With Us.

Next Steps

This offering is open for Accredited Investors only*

Review and complete the offering documents. The offering documents contain pertinent documents such as the PPM and Subscription Agreement.

EntelMed to review and accept your offering documents.

Wire investment within five (5) business days Investment slots will be offered by priority to those who submit their documents and wire their investment first.

IRA Funds are accepted. This may require converting your IRA to a self-directed IRA. Contact us for more information.

Help shape the future of Healthcare

FAQS

What makes EntelMed a unique investment opportunity?

EntelMed stands out due to its strategic focus on acquiring high-growth medical device companies. By consolidating these entities, we aim to create a powerhouse in the healthcare industry, targeting a $2.3 billion valuation through an eventual IPO.

What is the minimum investment required to participate?

EntelMed welcomes accredited investors with a minimum investment of $25,000 - designed to align with our strategic funding rounds.

How does EntelMed select companies for acquisition?

Our rigorous selection process focuses on companies with strong growth potential, innovative products, and the ability to integrate smoothly into our larger vision. We prioritize entities that complement our existing portfolio and align with our long-term strategic goals.

Nothing on this website should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by EntelMed or any third party. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. Investors and users should consult licensed legal professionals and investment advisors for any legal, tax, insurance, or investment advice.

*An accredited investor is defined as an individual who either:
Has earned income that exceeded $200,000 (or $300,000 together with a spouse) in each of the prior two years, and reasonably expects the same for the current year, OR
Has a net worth over $1 million, either alone or together with a spouse (excluding the value of their primary residence).